| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 25,803 | 22,682 | ||
| Short-term marketable securities | 61,098 | 62,021 | ||
| Prepaid expenses and other current assets | 4,063 | 2,681 | ||
| Total current assets | 90,964 | 87,384 | ||
| Long-term marketable securities | 88,930 | 102,702 | ||
| Operating lease right-of-use assets | 562 | 618 | ||
| Property and equipment, net | 318 | 314 | ||
| Other long-term assets | 1,530 | 1,368 | ||
| Total assets | 182,304 | 192,386 | ||
| Accounts payable | 477 | 946 | ||
| Accrued expenses and other current liabilities | 4,244 | 5,037 | ||
| Operating lease liabilities | 228 | 222 | ||
| Total current liabilities | 4,949 | 6,205 | ||
| Operating lease liabilities, net of current portion | 352 | 417 | ||
| Total liabilities | 5,301 | 6,622 | ||
| Common stock, 0.0001 par value 250,000,000 shares authorized 68,184,435 and 67,255,434 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 7 | 7 | ||
| Additional paid-in capital | 448,738 | 444,762 | ||
| Accumulated other comprehensive loss | 469 | 318 | ||
| Accumulated deficit | -272,211 | -259,323 | ||
| Total stockholders' equity | 177,003 | 185,764 | ||
| Total liabilities and stockholders' equity | 182,304 | 192,386 | ||
Climb Bio, Inc. (CLYM)
Climb Bio, Inc. (CLYM)